FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1489490018> ?p ?o ?g. }

• W1489490018 endingPage "146" @default.
• W1489490018 startingPage "135" @default.
• W1489490018 abstract "Allogeneic bone marrow or blood stem cell transplantation (BMT) represents an important therapeutic tool for the treatment of otherwise incurable malignant and non‐malignant diseases. Until recently, autologous and allogeneic bone marrow and mobilized blood stem cell transplantations were used primarily to replace malignant, genetically abnormal or deficient immunohematopoietic compartments, and therefore highly toxic myeloablative regimens were considered to be mandatory for the effective eradication of all undesirable host‐derived hematopoietic elements. Our preclinical and ongoing clinical studies have indicated that much more effective eradication of the host immunohematopoietic system cells can be achieved by adoptive allogeneic cell therapy with donor lymphocyte infusion following BMT. Thus, eradication of blood cancer cells, especially in patients with chronic myeloid leukemia and, less frequently, in patients with other hematologic malignancies, can frequently be accomplished despite the complete resistance of such tumor cells to maximally tolerated doses of chemoradiotherapy. Our cumulative experience has suggested that graft‐vs.‐leukemia (GVL) effects might be a useful tool for the eradication of otherwise resistant tumor cells of host origin. Based on the cumulative clinical experience and experimental data in animal models of human diseases, it appears that the induction of host‐vs.‐graft tolerance as an initial step may allow the durable engraftment of donor immunocompetent lymphocytes, which may be used for the induction of effective biologic warfare against host‐type immunohematopoietic cells that need to be replaced, including malignant, genetically abnormal or self‐reactive cells. Based on the aforementioned rationale, we speculated that the therapeutic benefit of BMT may be improved by using safer conditioning as part of the transplant procedure, with the goal being to induce host‐vs.‐graft tolerance to enable subsequent induction of GVL, possibly graft‐vs.‐tumor or even graft‐vs.‐autoimmunity effects, rather than attempting to eliminate host cells with hazardous myeloablative chemoradiotherapy. This hypothesis suggested that effective BMT procedures could be accomplished without lethal conditioning of the host, using new well‐tolerated non‐myeloablative regimens, thus possibly minimizing immediate and late side‐effects related to the myeloablative procedures until recently considered to be mandatory for the conditioning of BMT recipients. Recent clinical data presented in this review suggest that effective BMT procedures may be accomplished with well‐tolerated non‐myeloablative stem cell transplantation (NST) regimens, with no major toxicity. Thus, new NST approaches may offer the feasibility of safer BMT procedures for a large spectrum of clinical indications in children and elderly individuals, without lower or upper age limits, while minimizing procedure‐related toxicity and mortality. Taken together, our data suggest that high‐dose chemotherapy and radiation therapy may be successfully replaced by a more effective biologic tool, alloreactive donor lymphocytes, thus setting the stage for innovative therapeutic procedures for safer and more effective treatment of patients in need of BMT." @default.
• W1489490018 created "2016-06-24" @default.
• W1489490018 creator A5011851578 @default.
• W1489490018 creator A5030282008 @default.
• W1489490018 creator A5044345031 @default.
• W1489490018 creator A5051986774 @default.
• W1489490018 creator A5058925624 @default.
• W1489490018 creator A5059915616 @default.
• W1489490018 date "2001-06-01" @default.
• W1489490018 modified "2023-10-18" @default.
• W1489490018 title "NON-MYELOABLATIVE STEM CELL TRANSPLANTATION AND DONOR LYMPHOCYTE INFUSION FOR THE TREATMENT OF CANCER AND LIFE-THREATENING NON-MALIGNANT DISORDERS" @default.
• W1489490018 cites W1274344746 @default.
• W1489490018 cites W1479909146 @default.
• W1489490018 cites W1548609628 @default.
• W1489490018 cites W1707184873 @default.
• W1489490018 cites W1873141201 @default.
• W1489490018 cites W1912762949 @default.
• W1489490018 cites W1986288858 @default.
• W1489490018 cites W2001499325 @default.
• W1489490018 cites W2017413267 @default.
• W1489490018 cites W2018244870 @default.
• W1489490018 cites W2060136712 @default.
• W1489490018 cites W2082622575 @default.
• W1489490018 cites W2086594545 @default.
• W1489490018 cites W2108782166 @default.
• W1489490018 cites W2112041130 @default.
• W1489490018 cites W2158669275 @default.
• W1489490018 cites W2297816245 @default.
• W1489490018 cites W2318099690 @default.
• W1489490018 cites W2325605534 @default.
• W1489490018 cites W2327695677 @default.
• W1489490018 cites W2396781079 @default.
• W1489490018 cites W4246085869 @default.
• W1489490018 doi "https://doi.org/10.1046/j.1468-0734.2001.00036.x" @default.
• W1489490018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11486652" @default.
• W1489490018 hasPublicationYear "2001" @default.
• W1489490018 type Work @default.
• W1489490018 sameAs 1489490018 @default.
• W1489490018 citedByCount "33" @default.
• W1489490018 countsByYear W14894900182014 @default.
• W1489490018 countsByYear W14894900182016 @default.
• W1489490018 crossrefType "journal-article" @default.
• W1489490018 hasAuthorship W1489490018A5011851578 @default.
• W1489490018 hasAuthorship W1489490018A5030282008 @default.
• W1489490018 hasAuthorship W1489490018A5044345031 @default.
• W1489490018 hasAuthorship W1489490018A5051986774 @default.
• W1489490018 hasAuthorship W1489490018A5058925624 @default.
• W1489490018 hasAuthorship W1489490018A5059915616 @default.
• W1489490018 hasConcept C109159458 @default.
• W1489490018 hasConcept C121608353 @default.
• W1489490018 hasConcept C126322002 @default.
• W1489490018 hasConcept C203014093 @default.
• W1489490018 hasConcept C2777408962 @default.
• W1489490018 hasConcept C2777761686 @default.
• W1489490018 hasConcept C2778461978 @default.
• W1489490018 hasConcept C2779695342 @default.
• W1489490018 hasConcept C2780007613 @default.
• W1489490018 hasConcept C28328180 @default.
• W1489490018 hasConcept C2911091166 @default.
• W1489490018 hasConcept C502942594 @default.
• W1489490018 hasConcept C54355233 @default.
• W1489490018 hasConcept C71924100 @default.
• W1489490018 hasConcept C86803240 @default.
• W1489490018 hasConceptScore W1489490018C109159458 @default.
• W1489490018 hasConceptScore W1489490018C121608353 @default.
• W1489490018 hasConceptScore W1489490018C126322002 @default.
• W1489490018 hasConceptScore W1489490018C203014093 @default.
• W1489490018 hasConceptScore W1489490018C2777408962 @default.
• W1489490018 hasConceptScore W1489490018C2777761686 @default.
• W1489490018 hasConceptScore W1489490018C2778461978 @default.
• W1489490018 hasConceptScore W1489490018C2779695342 @default.
• W1489490018 hasConceptScore W1489490018C2780007613 @default.
• W1489490018 hasConceptScore W1489490018C28328180 @default.
• W1489490018 hasConceptScore W1489490018C2911091166 @default.
• W1489490018 hasConceptScore W1489490018C502942594 @default.
• W1489490018 hasConceptScore W1489490018C54355233 @default.
• W1489490018 hasConceptScore W1489490018C71924100 @default.
• W1489490018 hasConceptScore W1489490018C86803240 @default.
• W1489490018 hasIssue "2" @default.
• W1489490018 hasLocation W14894900181 @default.
• W1489490018 hasLocation W14894900182 @default.
• W1489490018 hasOpenAccess W1489490018 @default.
• W1489490018 hasPrimaryLocation W14894900181 @default.
• W1489490018 hasRelatedWork W2013057090 @default.
• W1489490018 hasRelatedWork W2046940509 @default.
• W1489490018 hasRelatedWork W2065010853 @default.
• W1489490018 hasRelatedWork W2069655943 @default.
• W1489490018 hasRelatedWork W2076802652 @default.
• W1489490018 hasRelatedWork W2079838338 @default.
• W1489490018 hasRelatedWork W2165369076 @default.
• W1489490018 hasRelatedWork W2323737189 @default.
• W1489490018 hasRelatedWork W3195146630 @default.
• W1489490018 hasRelatedWork W93914312 @default.
• W1489490018 hasVolume "5" @default.
• W1489490018 isParatext "false" @default.
• W1489490018 isRetracted "false" @default.
• W1489490018 magId "1489490018" @default.
• W1489490018 workType "article" @default.